JP2015521191A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2015521191A5 JP2015521191A5 JP2015514297A JP2015514297A JP2015521191A5 JP 2015521191 A5 JP2015521191 A5 JP 2015521191A5 JP 2015514297 A JP2015514297 A JP 2015514297A JP 2015514297 A JP2015514297 A JP 2015514297A JP 2015521191 A5 JP2015521191 A5 JP 2015521191A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- optionally
- filler
- disintegrant
- entecavir
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CA 2779052 CA2779052A1 (en) | 2012-05-31 | 2012-05-31 | Pharmaceutical composition of entecavir and process of manufacturing |
| CA2,779,052 | 2012-05-31 | ||
| PCT/CA2013/000517 WO2013177672A1 (en) | 2012-05-31 | 2013-05-28 | Pharmaceutical composition of entecavir and process of manufacturing |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2015521191A JP2015521191A (ja) | 2015-07-27 |
| JP2015521191A5 true JP2015521191A5 (enExample) | 2016-06-30 |
| JP6320371B2 JP6320371B2 (ja) | 2018-05-09 |
Family
ID=49672225
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2015514297A Active JP6320371B2 (ja) | 2012-05-31 | 2013-05-28 | エンテカビルの医薬組成物および製造方法 |
Country Status (9)
| Country | Link |
|---|---|
| US (2) | US20150110869A1 (enExample) |
| EP (1) | EP2854773B1 (enExample) |
| JP (1) | JP6320371B2 (enExample) |
| KR (1) | KR20150015500A (enExample) |
| CN (1) | CN104363896A (enExample) |
| CA (2) | CA2779052A1 (enExample) |
| HK (1) | HK1208620A1 (enExample) |
| IN (1) | IN2014MN02487A (enExample) |
| WO (1) | WO2013177672A1 (enExample) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3158998A4 (en) | 2014-06-20 | 2018-02-14 | CTC Bio, Inc. | Pharmaceutical preparation containing entecavir as active ingredient, and preparation method therefor |
| CN104473896B (zh) * | 2014-12-01 | 2017-04-19 | 东莞市金美济药业有限公司 | 一种快速崩解的拉米夫定片及其制备工艺 |
| HRP20240136T1 (hr) | 2016-06-29 | 2024-04-12 | Tesaro, Inc. | Metode liječenja raka jajnika |
| EP3606523A1 (en) * | 2017-03-27 | 2020-02-12 | Tesaro, Inc. | Niraparib formulations |
| AU2018246214B2 (en) | 2017-03-27 | 2021-07-08 | Merck Sharp & Dohme Llc | Niraparib compositions |
| CN111278433A (zh) | 2017-09-26 | 2020-06-12 | 特沙诺有限公司 | 尼拉帕尼制剂 |
| CN109550020A (zh) * | 2019-02-14 | 2019-04-02 | 任连智 | 一种治疗乙肝大小三阳的药物制剂及制备方法 |
| CN110354129A (zh) * | 2019-08-19 | 2019-10-22 | 苏州扬厉医药科技有限公司 | 一种治疗乙肝病毒的新药药物组合及制备方法 |
| AU2022289906A1 (en) * | 2021-06-07 | 2023-11-09 | R.P. Scherer Technologies, Llc | Protective coating for moisture sensitive pharmaceutical compositions |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2001229775A1 (en) * | 2000-02-29 | 2001-09-12 | Bristol-Myers Squibb Company | Low dose entecavir formulation and use |
| CA2311734C (en) * | 2000-04-12 | 2011-03-08 | Bristol-Myers Squibb Company | Flash-melt oral dosage formulation |
| EP1517678A2 (en) * | 2002-06-24 | 2005-03-30 | Ranbaxy Laboratories Limited | Process for the preparation of robust formulations of valacyclovir hydrochloride tablets |
| US7905852B2 (en) * | 2006-05-16 | 2011-03-15 | Barbara Jennings-Spring | Skin-contacting-adhesive free dressing |
| US20070281000A1 (en) * | 2006-06-02 | 2007-12-06 | Michael Fox | Stable formulation comprising moisture sensitive drug/s and manufacturing procedure thereof |
| CN101245068A (zh) * | 2007-02-14 | 2008-08-20 | 浙江医药股份有限公司新昌制药厂 | 结晶型态的恩替卡韦及其制备方法和其药物组合物及用途 |
| WO2009106954A1 (en) * | 2008-02-27 | 2009-09-03 | Aurobindo Pharma Limited | Stable dosage forms of lamivudine and tenofovir |
| WO2009106960A2 (en) * | 2008-02-27 | 2009-09-03 | Aurobindo Pharma Limited | Stable compositions of lamivudine, tenofovir and efavirenz |
| EP2467144A1 (en) * | 2009-07-24 | 2012-06-27 | ViroLogik GmbH | Combination of proteasome inhibitors and anti-hepatitis medication for treating hepatitis |
| WO2011076412A1 (de) * | 2009-12-23 | 2011-06-30 | Ratiopharm Gmbh | Orale darreichungsform umfassend entecavir |
| NZ610729A (en) * | 2010-11-19 | 2015-10-30 | Gilead Sciences Inc | Therapeutic compositions comprising rilpivirine hcl and tenofovir disoproxil fumarate |
| EP2508172A1 (en) * | 2011-04-06 | 2012-10-10 | Zentiva, a.s. | Stable and uniform formulations of entecavir and preparation method thereof |
| EP2780001A4 (en) * | 2011-11-14 | 2015-10-28 | Hetero Research Foundation | SOLID ORAL ENTECAVIR COMPOSITIONS WITH FAST RELEASE |
| WO2013114389A1 (en) * | 2011-12-21 | 2013-08-08 | Mylan Laboratories Limited. | Process for preparing solid oral formulations comprising low dose of entecavir |
-
2012
- 2012-05-31 CA CA 2779052 patent/CA2779052A1/en not_active Abandoned
-
2013
- 2013-05-28 EP EP13797878.9A patent/EP2854773B1/en active Active
- 2013-05-28 KR KR20147034899A patent/KR20150015500A/ko not_active Ceased
- 2013-05-28 HK HK15109146.7A patent/HK1208620A1/xx unknown
- 2013-05-28 IN IN2487MUN2014 patent/IN2014MN02487A/en unknown
- 2013-05-28 CA CA2874779A patent/CA2874779C/en active Active
- 2013-05-28 CN CN201380030696.6A patent/CN104363896A/zh active Pending
- 2013-05-28 WO PCT/CA2013/000517 patent/WO2013177672A1/en not_active Ceased
- 2013-05-28 US US14/404,176 patent/US20150110869A1/en not_active Abandoned
- 2013-05-28 JP JP2015514297A patent/JP6320371B2/ja active Active
-
2018
- 2018-04-03 US US15/944,452 patent/US20190076366A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA2870868C (en) | Orally disintegrating tablet and production process therefor | |
| JP6301934B2 (ja) | チカグレロルを含む固形経口医薬製剤 | |
| JP6320371B2 (ja) | エンテカビルの医薬組成物および製造方法 | |
| JP2017525712A5 (enExample) | ||
| JP2015518885A5 (enExample) | ||
| EP3606511A1 (en) | Pharmaceutical composition comprising lenvatinib mesylate | |
| WO2017182455A1 (en) | Stable pharmaceutical composition of amorphous ticagrelor | |
| CN105377240A (zh) | 固体药物剂型 | |
| JP2010120959A5 (enExample) | ||
| EP3326619B1 (en) | Solid oral pharmaceutical compositions comprising tenofovir and emtricitabine | |
| JP2013544272A5 (enExample) | ||
| KR20110085307A (ko) | 난용성 약물을 함유하는 경구 제형 | |
| WO2016079687A1 (en) | Oral pharmaceutical composition of teriflunomide | |
| WO2015069203A1 (en) | Capsule comprising rupatadine fumarate and montelukast sodium | |
| JP7336528B2 (ja) | ネフォパムおよびアセトアミノフェンを含む薬学的組成物の製造方法、およびそれによって得られる薬学的組成物 | |
| DK3166596T3 (en) | Pharmaceutical dosage forms | |
| JP2019034914A (ja) | 良好な徐放性を有する、レボドパ含有小型化錠剤 | |
| JP6227352B2 (ja) | アナグリプチン又はその塩を含有する固形製剤 | |
| JP2019065032A5 (enExample) | ||
| EP2391350A1 (en) | Atazanavir formulations | |
| JP6336651B1 (ja) | 化学的安定性が改善されたエソメプラゾール塩を含有する錠剤 | |
| RU2021108451A (ru) | Фармацевтическая композиция для перорального введения | |
| WO2017198783A1 (en) | New oral pharmaceutical formulations of dabigatran | |
| EA043966B1 (ru) | Твердая фармацевтическая композиция на основе тикагрелора для перорального применения | |
| JP2015183001A (ja) | ワルファリン含有固形製剤及びその製造方法 |